CSPC Pharmaceutical Group Ltd 2024 Sustainability Report
Company: CSPC Pharmaceutical Group Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 133
The report highlights CSPC's RMB 5.191 billion investment in R&D during 2024, supporting innovative medicines and global research capabilities. The company had 21,379 employees at year-end and reported zero fatalities and zero severe injury accidents. Its environmental program included green-factory upgrades, renewable electricity use, and achievement of a 53% reduction in greenhouse gas emissions per unit of revenue against the 2017 baseline.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.